Abstract
Growth impairment and bone toxicity due to tenofovir disoproxil fumarate (TDF) fetal exposure has been described mainly in animals. We evaluated growth pattern and bone health in TDF-exposed HIV-uninfected children born to HIV-infected mothers, defined as seroreverters (SR).
| Original language | English |
|---|---|
| Pages (from-to) | 1259-1266 |
| Number of pages | 8 |
| Journal | Antiviral Therapy |
| Volume | 16 |
| DOIs | |
| Publication status | Published - 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenine
- Adult
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- Bone and Bones
- Child
- Child, Preschool
- Cohort Studies
- Cross-Sectional Studies
- Female
- Fetus
- HIV
- HIV Infections
- HIV Seropositivity
- Humans
- Infant
- Infectious Disease Transmission, Vertical
- Italy
- Male
- Observation
- Phosphonic Acids
- Pregnancy
- Reverse Transcriptase Inhibitors
Fingerprint
Dive into the research topics of 'In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver